Carstens M, Weller M
Biochim Biophys Acta. 1979 Mar 8;551(2):420-31. doi: 10.1016/0005-2736(89)90017-5.
The ability of membrane preparations from different tissues to catalyse the phosphorylation of their endogenous protein (intrinsic protein kinase activity) was determined. It was found that membrane fragments prepared from a large variety of tissues contain this activity although the actual level varies quite widely. Preparations from vas deferens and brain have nearly ten times more activity than preparations from heart, kidney, or erythrocytes. Plasma membranes from skeletal muscle have no detectable activity. The intrinsic protein kinase activity of membrane fragments from most tissues is stimulated by cyclic AMP although the phosphorylation of proteins in preparations of kidney microsomes or heart plasma membranes, is not affected. cyclic GMP (10 micronM) has no effect on the intrinsic protein kinase activity of any membrane preparation examined. A specific inhibitor of soluble, cyclic AMP-stimulated, protein kinase has no effect on the intrinsic protein kinase activity of any of the membrane preparations examined. This suggests that the intrinsic protein kinase activity of membrane preparations may be due to the presence of a specific protein kinase. It is suggested that an examination of the distribution of membrane-bound intrinsic protein kinase activity among different tissues may be helpful in determining the function of the reaction.
测定了来自不同组织的膜制剂催化其内源性蛋白质磷酸化的能力(内在蛋白激酶活性)。结果发现,尽管实际水平差异很大,但从多种组织制备的膜片段都含有这种活性。输精管和脑的制剂的活性几乎是心脏、肾脏或红细胞制剂的十倍。骨骼肌的质膜没有可检测到的活性。大多数组织的膜片段的内在蛋白激酶活性受到环磷酸腺苷(cAMP)的刺激,尽管肾脏微粒体或心脏质膜制剂中的蛋白质磷酸化不受影响。环磷酸鸟苷(cGMP,10微摩尔)对所检测的任何膜制剂的内在蛋白激酶活性均无影响。可溶性、cAMP刺激的蛋白激酶的特异性抑制剂对所检测的任何膜制剂的内在蛋白激酶活性均无影响。这表明膜制剂的内在蛋白激酶活性可能归因于一种特异性蛋白激酶的存在。有人提出,研究膜结合内在蛋白激酶活性在不同组织中的分布可能有助于确定该反应的功能。